Medical diagnostics company Omega expects to report a 41% increase in revenues from £8.7m to £12.3m during the year ended 31 March 2022 - but is still seeking sources of funding, following a failed share offer last month.
A trading update explained that its health and nutrition division contributed £8.6m of revenue - up from £6.8m in 2021. Sales for the division last year were skewed by a large stocking order worth approximately £1.2m placed by the company’s largest partner in China to seed the market.
Excluding this stocking order from last year, underlying health and nutrition sales grew by 54%, driven by strong Food Print product sales; up 82%.
